Acute Pancreatitis News and Research

RSS
Acute pancreatitis is a sudden inflammation of the pancreas. Depending on its severity, it can have severe complications and high mortality despite treatment. While mild cases are often successfully treated with conservative measures, such as NPO (nil by mouth or NBM) and IV fluid rehydration, severe cases may require admission to the ICU or even surgery (often requiring more than one intervention) to deal with complications of the disease process.
Amylin's new metreleptin data in lipodystrophy to be presented at AACE meeting

Amylin's new metreleptin data in lipodystrophy to be presented at AACE meeting

Consumer group calls for ban on weight loss drugs Alli and Xenical

Consumer group calls for ban on weight loss drugs Alli and Xenical

New insight into acute pancreatitis

New insight into acute pancreatitis

Cardiff study discovers protein that protects pancreatic cells against alcohol effects

Cardiff study discovers protein that protects pancreatic cells against alcohol effects

New study: Alcohol-related chronic pancreatitis is lower than other causes

New study: Alcohol-related chronic pancreatitis is lower than other causes

Baxter launches OLIMEL emulsion for parenteral nutrition

Baxter launches OLIMEL emulsion for parenteral nutrition

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Study finds combined treatments safe and effective for severe acute pancreatitis

Study finds combined treatments safe and effective for severe acute pancreatitis

Amylin, Lilly submit BYETTA sNDA for type 2 diabetes

Amylin, Lilly submit BYETTA sNDA for type 2 diabetes

Amylin submits metreleptin rolling submission BLA for treatment of rare forms of lipodystrophy

Amylin submits metreleptin rolling submission BLA for treatment of rare forms of lipodystrophy

FDA issues complete response letter for BYDUREON NDA

FDA issues complete response letter for BYDUREON NDA

USPTO grants two additional patents to Ryogen

USPTO grants two additional patents to Ryogen

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

PGIC analysis indicates tapentadol ER tablets provide significant improvement in pain intensity

Progenika receives CE Mark approval to market LPLchip in Europe

Progenika receives CE Mark approval to market LPLchip in Europe

Study observes enteral nutrition outcome in patients with severe acute pancreatitis

Study observes enteral nutrition outcome in patients with severe acute pancreatitis

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Amylin reports $164.4M total revenue for quarter ended June 30, 2010

Amylin reports $164.4M total revenue for quarter ended June 30, 2010